{"id":123709,"name":"ALLIANCE OF COMMUNITY HEALTH PLANS, INC.","slug":"alliance-of-community-health-plans-inc","state":"DC","country":"United States of America","description":"","totalSpending":17940000,"filings":35,"yearlySpending":[{"year":2018,"income":2920000},{"year":2019,"income":1910000},{"year":2020,"income":1970000},{"year":2021,"income":2170000},{"year":2022,"income":2210000},{"year":2023,"income":2500000},{"year":2024,"income":2120000},{"year":2025,"income":2140000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"MMM","display":"Medicare/Medicaid"}],"firms":["ALLIANCE OF COMMUNITY HEALTH PLANS, INC."],"lobbyists":["HOWARD SHAPIRO","ANDREW SCHWAB","SEEMIN PASHA","TRICIA BROOKS","TRICIA BARRENTINE GUAY","MICHAEL BAGEL","MATTHEW DOBIAS","ANTHONY MONTOYA","DANIEL JONES","MICHAEL ANGELONI","VIRGINIA WHITMAN","NISSA SHAFFI","CHRISTOPHER DEVORE","JOSHUA JORGENSEN","NORA DICKSON","CARMEN WITSKEN","MADELINE O'BRIEN"],"govEntities":["Centers For Medicare and Medicaid Services (CMS)","Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE","Executive Office of the President (EOP)","Office of Management & Budget (OMB)","Substance Abuse & Mental Health Services Administration (SAMHSA)","Food & Drug Administration (FDA)"],"sampleDescriptions":["Legislation changing the Affordable Care Act; stability of the individual market; prescription drug costs; tax credits and cost-sharing reduction subsidies; insurer taxes; affordability","Medicare Advantage (Part C) and Prescription Drug (Part D) programs: quality measures and ratings system; quality incentive payments; Special Needs Plans; risk adjustment; coverage of telehealth-based","Legislation changing the Affordable Care Act; stability of the individual market; prescription drug costs; tax credits and cost-sharing reduction subsidies; insurer taxes; affordability; opioids legis","Medicare Advantage (Part C) and Prescription Drug (Part D) programs: quality measures and ratings system; quality incentive payments; Special Needs Plans; risk adjustment; coverage of telehealth-based","Medicare Advantage (Part C) and Prescription Drug (Part D) programs: quality measures and ratings system; quality incentive payments; Special Needs Plans; risk adjustment; coverage of telehealth-based"]}